Recombinant TFPI and variants:potential implications in the treatment of cardiovascular disorders

Author： Kaiser B. Hoppensteadt D.H. Fareed J.

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.7, Iss.7, 1998-07, pp. : 1121-1139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders

By Hoppensteadt Debra A Kaiser Brigitte Fareed Jawed

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 11, 2001-11 ,pp. : 1925-1935

Informa Healthcare

Access to resources Recommend Favorite

Cellular Senescence in Cardiovascular Diseases: Potential Age-Related Mechanisms and Implications for Treatment

Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-03 ,pp. : 1710-1719

Bentham Science Publishers

Access to resources Recommend Favorite

The Genomics of Cardiovascular Disorders: Therapeutic Implications

By Ferrari P.

Drugs, Vol. 59, Iss. 5, 2000-05 ,pp. : 1025-1042

Adis International

Access to resources Recommend Favorite

Therapeutic Potential of Renin Inhibitors in the Management of Cardiovascular Disorders

By Stanton A.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 6, 2003-01 ,pp. : 389-394

Adis International

Access to resources Recommend Favorite

Therapeutic Potential for Endothelin Receptor Antagonists in Cardiovascular Disorders

By Spieker L.E. Noll G. Lüscher T.F.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 4, 2001-04 ,pp. : 293-303

Adis International

Access to resources Recommend Favorite